Business NewsPR NewsWire • ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug

ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug

ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug

TAINAN, Taiwan, Aug. 5, 2016 /PRNewswire/ -- ScinoPharm Taiwan, Ltd (TWSE: 1789) and CVie Therapeutics Limited (CVie) jointly announced the initiation of a discovery and development collaboration to identify the new generation compound to Istaroxime, CVie's acute heart failure treatment...

View More : http://www.prnewswire.com/news-releases/scinopharm-and-cvie-therapeutics-limited-to-jointly-develop-new-heart-failure-dr...
Releted News by prnewswire
Perfect World Attracts Wide Attention at 2016 ChinaJoy
ScinoPharm and CVie Therapeutics Limited to Jointly Develop New Heart Failure Drug
Sixty-One Percent of Occupations Projected to Lose Jobs Over the Next Five Years are Middle-Wage, According to CareerBuilder and Emsi Research